P533 Correlation of endoscopic and clinical endpoints during induction therapy in patients with moderate-to-severe Crohn’s disease: Analysis from CELEST studyWilliam J. Sandborn, Ana P. Lacerda, B. Feagan et al.|Journal of Crohn s and Colitis|2018Cited by 3
P067 ANALYSES ON QUALITY-ADJUSTED LIFE-YEARS (QALY) IN TWO INDUCTION AND MAINTENANCE TRIALS OF CERTOLIZUMAB PEGOL IN PATIENTS WITH ACTIVE CROHN'S DISEASEB. Feagan, M. Brown, Samuel Chin Wei Tan|Journal of Crohn s and Colitis Supplements|2008Cited by 0